Risks and Returns of Idexx Laboratories, Inc. (IDXX) Stock
Piper Sandler raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock from “an Overweight” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The stock was downgraded by Atlantic Equities, who disclosed in a research note on August 02, 2023, from Overweight to Neutral and set the price […]
In the current cycle, Idexx Laboratories, Inc. (IDXX) Stock is showing signs of growth
Piper Sandler raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock from “an Overweight” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The stock was downgraded by Atlantic Equities, who disclosed in a research note on August 02, 2023, from Overweight to Neutral and set the price […]
Where are Investors’ Sentiments? Idexx Laboratories, Inc. (IDXX) Stock
Piper Sandler raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock from “an Overweight” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The stock was downgraded by Atlantic Equities, who disclosed in a research note on August 02, 2023, from Overweight to Neutral and set the price […]
Idexx Laboratories, Inc. (NASDAQ:IDXX) Stock Price Advanced 2.06% to $499.30
Piper Sandler raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock from “an Overweight” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The stock was downgraded by Atlantic Equities, who disclosed in a research note on August 02, 2023, from Overweight to Neutral and set the price […]
